IDH1 and cancer: Mutations in IDH1 have been reported in various types of cancer, particularly in low-grade gliomas18,19, cholangiocarcinoma14, lung cancer17, renal cancer6, pancreatic adenocarcinoma15, and gastrointestinal cancer11.